James L Tyree Insider Trading $CCXI ChemoCentryx, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James L Tyree.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James L Tyree. James L Tyree is Executive Vice President in ABBOTT LABORATORIES ($ABT) and Senior Vice President in ABBOTT LABORATORIES ($ABT) and Director in DEPOMED INC ($DMI) and Director in Innoviva, Inc. ($THRX) and Director in ChemoCentryx, Inc. ($CCXI) and Director in Assertio Holdings, Inc. ($ASRT).
James L Tyree in ChemoCentryx, Inc.
Trading Symbol: CCXIIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James L Tyree: Director
Holdings: 13,069 shares
Current Value: $87,170
Latest Transaction: May 26 2020
$CCXI Market Capitalization: $309.30M
$CCXI Previous Close: $6.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of James L Tyree in ChemoCentryx, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ABT, ASRT, DMI, CCXI, THRX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 26 2020 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | M | 0.00 | 7,724 | 0 | 0 | |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | A | 0.00 | 4,660 | 0 | 4,660 | |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | A | 59.73 | 2,888 | 172,500 | 2,888 | |
May 26 2020 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Buy | M | 0.00 | 7,724 | 0 | 13,069 | 5.3 K to 13.1 K (+144.51 %) |
Jan 15 2020 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Sell | S | 37.44 | 14,715 | 550,916 | 5,345 | 20.1 K to 5.3 K (-73.35 %) |
Jan 15 2020 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Sell | S | 36.69 | 15,285 | 560,770 | 20,060 | 35.3 K to 20.1 K (-43.25 %) |
May 23 2019 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | A | 11.60 | 12,287 | 142,529 | 12,287 | |
May 23 2019 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | A | 0.00 | 7,724 | 0 | 7,724 | |
May 23 2019 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | M | 0.00 | 8,421 | 0 | 0 | |
May 23 2019 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Buy | M | 0.00 | 8,421 | 0 | 35,345 | 26.9 K to 35.3 K (+31.28 %) |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | A | 12.94 | 13,352 | 172,775 | 13,352 | |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | A | 0.00 | 8,421 | 0 | 8,421 | |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | A | 12.94 | 13,352 | 172,775 | 13,352 | |
May 23 2018 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | A | 0.00 | 8,421 | 0 | 8,421 | |
May 30 2017 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | M | 0.00 | 20,362 | 0 | 0 | |
May 30 2017 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Buy | M | 0.00 | 20,362 | 0 | 53,849 | 33.5 K to 53.8 K (+60.81 %) |
May 30 2017 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Grant | A | 0.00 | 12,912 | 0 | 33,487 | 20.6 K to 33.5 K (+62.76 %) |
May 27 2016 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | A | 0.00 | 20,362 | 0 | 20,362 | |
May 24 2016 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | M | 0.00 | 11,795 | 0 | 0 | |
May 24 2016 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Sell | S | 4.39 | 5,544 | 24,337 | 20,575 | 26.1 K to 20.6 K (-21.23 %) |
May 24 2016 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Buy | M | 0.00 | 11,795 | 0 | 26,119 | 14.3 K to 26.1 K (+82.34 %) |
May 26 2015 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | M | 0.00 | 27,027 | 0 | 0 | |
May 26 2015 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Option Exercise | A | 0.00 | 11,795 | 0 | 11,795 | |
May 26 2015 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Sell | S | 7.45 | 12,703 | 94,593 | 14,324 | 27 K to 14.3 K (-47.00 %) |
May 26 2015 | CCXI | ChemoCentryx, Inc. | Tyree James L | Director | Buy | M | 0.00 | 27,027 | 0 | 27,027 | 0 to 27 K |
Page: 1